Antioxidant treatment attenuates age-related placenta GLUT-1 and PLIN-2 downregulation

Placenta. 2025 Feb:160:60-66. doi: 10.1016/j.placenta.2024.12.024. Epub 2024 Dec 30.

Abstract

Background and aim: Pregnancy after the age of 35 is correlated with an increased risk of impaired placentation and the development of pregnancy-associated complications. Changes in uterine redox balance seem to play a role in these settings. In this work, we hypothesized that local redox dysregulation impacts the placenta metabolic profile. Thus, we aimed to study the expression of enzymes/transporters related to nutrient uptake during reproductive aging and the effect of antioxidant supplementation.

Methods: Placenta samples were collected from pregnant women aged between 22 and 41 years, and from mice of different reproductive ages (8-12 and 38-42 weeks). A subgroup of 38-42 weeks-old mice was treated with apocynin (5 mM) in the drinking water. Real-time PCR was carried out to assess gene expression, and immunohistochemistry or western blotting to assess protein expression.

Results: A significant age-related decrease in the expression of glucose transporter type 1 (GLUT-1) was observed in both species. Regarding lipid metabolism, there was a strong negative and significant correlation between the gene expression of fatty-acid transporter type 4 and maternal age, in the human placenta. Perilipin isoform 2 (PLIN-2) decreased significantly with maternal age, in both models. Additionally, a significant age-related decrease in the gene expression of large neutral amino acid transporter type 4 with reproductive age was observed in the mice placenta. Supplementation with apocynin attenuated the observed alterations in GLUT-1 and PLIN-2. The observed changes suggest an age-related placenta metabolic dysfunction, likely associated with oxidative stress, that may negatively impact fetal and placental development.

Keywords: Apocynin; GLUT-1; PLIN-2; Placenta; Reproductive aging.

MeSH terms

  • Acetophenones* / pharmacology
  • Adult
  • Aging* / metabolism
  • Animals
  • Antioxidants* / pharmacology
  • Down-Regulation / drug effects
  • Female
  • Glucose Transporter Type 1* / genetics
  • Glucose Transporter Type 1* / metabolism
  • Humans
  • Maternal Age
  • Mice
  • Perilipin-2* / genetics
  • Perilipin-2* / metabolism
  • Placenta* / drug effects
  • Placenta* / metabolism
  • Pregnancy
  • Young Adult

Substances

  • Glucose Transporter Type 1
  • Antioxidants
  • Perilipin-2
  • Acetophenones
  • acetovanillone